FDA Warning Letter — BLS Labs LLC

Case 621465 — FEI 3030597722

The FDA took a Warning Letter action against BLS Labs LLC on Aug 23, 2022 (Mesa, AZ). The action was issued by CBER and concerns biologics products. This facility has 3 recent FDA inspections on record.

Action details

Facility
BLS Labs LLC
Date
Aug 23, 2022
Fiscal Year
2022
Product Type
Biologics
Center
CBER
Location
Mesa, AZ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.